Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Acquisition

21 Aug 2006 07:00

Marchpole Holdings PLC21 August 2006 MARCHPOLE HOLDINGS PLC ("Marchpole" ) Acquisition of unique lifestyle brand Homebody Marchpole Holdings plc, the fast growing fashion brand management group, ispleased to announce that it has today agreed to acquire the luxury clothingcompany Homebody Limited. Homebody, which was founded in 1997 by Beverley Calvert, designs, manufacturesand distributes a luxury lifestyle collection of ladieswear, maternity wear andmenswear designed by Beverley and Susannah Draper. Marchpole has acquired an initial 51 per cent interest in Homebody with theremaining 49 per cent being acquired after three years based on an earn outformula. The maximum aggregate consideration for the acquisition will not exceed£1.35 million. The initial consideration will be satisfied in cash from theCompany's existing resources and the final consideration will be satisfied inMarchpole shares, cash or a combination of the two at Marchpole's discretion. Beverley Calvert and Susannah Draper will remain at the creative helm of thebusiness and will continue to develop their brand with Marchpole. Homebody, which has wholesale, retail and internet customers, has secured aunique position in the lifestyle category and is a fast growing brand in the UKand US. Marchpole will build the brand throughout Europe and the US throughincreased distribution outlets, leveraging the demand for the excellent designsand creativity of Homebody The Homebody collection is stocked in Selfridges and Harrods as well as topboutiques across the UK. International stockists include Neiman Marcus and FredSegal. The collection is featured regularly in Vogue, Glamour, Grazia andHarpers Bazaar and has a significant celebrity following. Michael Morris, Executive Deputy Chairman of Marchpole, commented : "We are delighted to be integrating Homebody into the Marchpole collection ofglobally recognised fashion labels. The acquisition is another significant steptowards the evolution of the company into an international brand managementgroup. We believe that there is considerable growth potential for the Homebodybusiness. We have proven expertise in sourcing, manufacturing and marketing anda worldwide distribution capability, which allied to the design strengths of Beverley and Susannah, will accelerate that growth." For further information, please contact : Emma KentBell Pottinger Corporate & Financial 020 7861 3232 John Harrison, Finance DirectorMarchpole 020 7908 7777 Note to Editors : • Marchpole Holdings plc ("Marchpole") is an international brand management group that designs, produces and sells clothing and accessories for eight globally recognised fashion labels. It operates in all of the world's main markets - UK, mainland Europe, Asia and the USA • Its respected brands include YSL, Boateng, Emmanuel Ungaro, Ungaro, Jean-Charles de Castelbajac ("JCC"), Jean-Charles de Castelbajac / Rossignol, Jean-Charles de Castelbajac/Okaidi and Homebody • Marchpole is renowned for its integrated approach to brand management, taking a brand from concept to design studio to the customer interface. It is not a clothing manufacturer • The Group has grown considerably in the past 3 years, from a licensee with one core license (YSL menswear) - to today's international business that manages its brands across a multitude of clothing lines and accessories • Marchpole's recent acquisition (March 2006) of Moda America - the US licensee for leading designer Emanuel Ungaro - brings further growth opportunities in the UK and America and strengthens the company's relationship with Ungaro • The acquisition also allows the company to launch the Ungaro brand, already established by Marchpole in Europe and Asia, into the US, Canada and South America. The acquisition also allows the company to re-launch JCC into America with effect from autumn/winter 2006 • Marchpole will launch the diffusion Ungaro Homme collection in the UK from Spring/Summer 2007 For further information on Homebody please visit: www.homebodylondon.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Sep 20191:00 pmRNSNotice of Results
6th Sep 20197:00 amRNSBlock listing Interim Review
4th Sep 20191:00 pmRNSMereo announces phase 2b data at ASBMR Meeting
16th Aug 20191:51 pmRNSDirector/PDMR Shareholding
15th Aug 20194:59 pmRNSPDMR Shareholding
12th Aug 20194:41 pmRNSSecond Price Monitoring Extn
12th Aug 20194:35 pmRNSPrice Monitoring Extension
9th Aug 20194:35 pmRNSPrice Monitoring Extension
31st Jul 201912:51 pmRNSDirector Declaration
25th Jul 20194:56 pmRNSPDMR Shareholding
24th Jul 201910:08 amRNSDirector/PDMR Shareholding
19th Jul 20191:21 pmRNSDirector/PDMR Shareholding
16th Jul 20191:00 pmRNSAppointment of Richard Francis
15th Jul 20191:00 pmRNSSuccessful Type B Meeting with U.S. FDA
8th Jul 20193:54 pmRNSHolding(s) in Company
3rd Jul 20194:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20194:35 pmRNSPrice Monitoring Extension
27th Jun 20193:33 pmRNSHolding(s) in Company
26th Jun 20194:36 pmRNSHolding(s) in Company
21st Jun 20191:00 pmRNSConversion of loan note and issue of equity
20th Jun 20197:00 amRNSResult of AGM
13th Jun 20191:00 pmRNSUpdate on Etigilimab (TIGIT) Partnership
30th May 20197:00 amRNSPositive early 6 month data
23rd May 20194:11 pmRNSDirector/PDMR Shareholding
22nd May 20199:45 amRNSPDMR Shareholding
21st May 20193:08 pmRNSDirector/PDMR Shareholding
20th May 20197:00 amRNSNotice of AGM
8th May 20191:53 pmRNSDirector/PDMR Shareholding
7th May 20197:00 amRNSIssue of Warrants
7th May 20197:00 amRNSRe-release: Intention to Purchase Shares
3rd May 20195:00 pmRNSIntention to Purchase Shares by Trustee of EBT
3rd May 20192:02 pmRNSDirector/PDMR Shareholding
1st May 20193:47 pmRNSDirector/PDMR Shareholding
30th Apr 20193:15 pmRNSDirector/PDMR Shareholding
30th Apr 20197:00 amRNSDirector/PDMR Shareholding
30th Apr 20197:00 amRNSPublication of Annual Report and Accounts
29th Apr 20197:00 amRNSPrelims Results for year ended December 31 2018
26th Apr 20193:01 pmRNSDirector/PDMR Shareholding
25th Apr 20193:36 pmRNSHolding(s) in Company
25th Apr 20193:29 pmRNSHolding(s) in Company
24th Apr 20192:30 pmRNSAdmission to Trading
23rd Apr 20192:25 pmRNSCompletion of Merger
18th Apr 20197:00 amRNSMerger Update
15th Apr 20197:00 amRNSSuccessful end of Phase 2 Meeting with FDA
21st Mar 20197:00 amRNSPublication of Form F-4
15th Mar 201911:45 amRNSUpdate on Proposed Combination of Mereo & OncoMed
13th Mar 201911:00 amRNSMereo CEO appointed NED of Elanco Animal Health
6th Mar 20197:00 amRNSBlock Listing Interim Review
5th Mar 20191:32 pmRNSMereo to present at Cowen and Company Conference
22nd Feb 20191:50 pmRNSUpdate on Proposed Transaction with OncoMed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.